美股马甲2015-06-18 09:29
$Avalanche Biotechnologies(AAVL)$ Piper Jaffray's Steven P. Breazzano maintained an Overweight rating and $52 target.查看全文
淡投2015-06-18 08:47
网页链接
did his medical training at Harvard’s Mass Eye & Ear Infirmary (ophthalmology), Stanford Hospital (internal medicine) and UCSF (pathology). it has 13% of portifolio in $Avalanche Biotechnologies(AAVL)$ based upon 3/31 filing查看全文
割资本主义羊毛2015-06-17 03:37
受$Avalanche Biotechnologies(AAVL)$ 影响,gt组全线回调,当然,$Celladon Corporation(CLDN)$ 作为垃圾股已免疫,垃圾股行情又添新成员$Avalanche Biotechnologies(AAVL)$
幸存的GT组员:$SPARK THERAPEUTICS INC(ONCE)$ $BLUEBIRD BIO INC(BLUE)$ $uniQure(QURE)$ $Applied Genetic...查看全文
郑坚强2015-06-16 20:51
$Avalanche Biotechnologies(AAVL)$ 果然是mixed data,达到了primary endpoint,但是效果不显著,视敏度只增加了2.2,还出现了一个视网膜增厚的问题,昨天尾盘也是直接被拉到52,最后十几分钟解决战斗投行的评级也是各有不同:jeffies,piper jaffray依然给出了TP 50多,其他一些基本都是20...查看全文
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2015-06-30 AccNo: 0001193125-15-239824 Size: 17 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2015-06-15 AccNo: 0001193125-15-223519 Size: 40 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2015-05-13 AccNo: 0001193125-15-184900 Size: 60 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-08-13 AccNo: 0001193125-15-290017 Size: 3 MB 网页链接
$Avalanche Biotechnologies(AAVL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-05-13 AccNo: 0001193125-15-185889 Size: 3 MB 网页链接
$Avalanche Biotechnologies(AAVL)$ 内部交易: 2015-06-12,SVP, Business Operations,Hull Hans ,期权,8300普通股, $0.19
$Avalanche Biotechnologies(AAVL)$ 内部交易: 2015-06-12,CFO,Bain Linda ,卖出,3500普通股, $39.94
$Avalanche Biotechnologies(AAVL)$ 内部交易: 2015-06-12,CFO,Bain Linda ,期权,3500普通股, $3.15
$Avalanche Biotechnologies(AAVL)$ 内部交易: 2015-06-11,Director,Blumenkranz Mark S. ,卖出,1900普通股, $39.97
$Avalanche Biotechnologies(AAVL)$ 内部交易: 2015-06-10,CEO,Chalberg Thomas W. ,卖出,25000普通股, $38.05